Concepedia

Gurunadh R. Chichili

GR

22

Publications

1.4K

Citations

17

H-Index

2003

Active since

Affiliations

MacroGenics (United States)(Current)

University of Oklahoma Health Sciences Center

Oklahoma Medical Research Foundation

Astellas Pharma (United States)

Université Paris Cité

Gurunadh R. Chichili is an author at MacroGenics (United States) specializing in medicine, radiation oncology, and immunology.

Top concepts

Publications per year

2003–2024

22

Publications

22

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

Yung‐Jue Bang, Giuseppe Giaccone, S.-A. Im et al. · Annals of Oncology · 2017 · 224 citations · Full text

, , +8

Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform

Muneera Al-Hussaini, Michael P. Rettig, Julie Ritchey et al. · Blood · 2015 · 172 citations · Full text

A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates

Gurunadh R. Chichili, Ling Huang, Hua Li et al. · Science Translational Medicine · 2015 · 165 citations

Clustering of Membrane Raft Proteins by the Actin Cytoskeleton

Gurunadh R. Chichili, William Rodgers · Journal of Biological Chemistry · 2007 · 128 citations · Full text

, , +16

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

Adam Root, Wei Cao, Bilian Li et al. · Antibodies · 2016 · 92 citations · Full text

Rows per page

1–5 of 22